A Study in Healthy Volunteers to Evaluate Serum and Urine Levels of the Investigational Product Versus Comparator.

Dey Pharma

Status and phase: Completed; Phase 1

Conditions: Healthy

Treatments: Drug: Fluticasone Propionate; Drug: Formoterol Fumarate

Study type: Interventional

Funder types: Industry

Identifiers

NCT00280358

191-072

Details and patient eligibility

About

The purpose of the study is to obtain initial pharmacokinetic data in healthy patients after dosing a combination of the study medications.

Sex: All

Ages: 18 to 60 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Non-smokers, BMI 18-29, no current medications

Exclusion criteria

• Significant conditions or disease

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Crossover Assignment

Masking: None (Open label)